Premature ovarian failure
Conditions
Interventions
Observation Group:Taking Femtomax and Yijing Decoction
Control group:Taking Femtomax
Sponsors
Shunde Women and Childrens Hospital Guangdong Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1) Amenorrhoea of at least 4 months duration with 2 or more serum follicle stimulating hormone (FSH) >40 U/L (more than 1 month between tests) and oestradiol <73.2 pmol/L 2) Age range between 18-40 years 3) Have fertility requirements 4) Those who voluntarily participate in this study have good compliance can follow medical advice and co-operate with follow-up observation
Exclusion criteria
Exclusion criteria: 1) Those who had taken hormone therapy in the three months prior to enrolment 2) Those who suffer from neurological cardiovascular haematological or immune system diseases or those with abnormal infectious diseases 3) Those who cannot be followed up regularly for various reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum sex hormone levels; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ovarian sinus follicle count;Pregnancy; | — |
Countries
China
Contacts
Public ContactYudan Guo
Shunde Women and Children's Hospital, Guangdong Medical University
Outcome results
None listed